DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,349,078 | -46.6% | 119,918 | -45.3% | 0.21% | -50.0% |
| Q1 2023 | $2,526,520 | +2949.3% | 219,316 | +2967.8% | 0.42% | +2244.4% |
| Q4 2022 | $82,857 | -93.4% | 7,149 | -93.2% | 0.02% | -87.0% |
| Q4 2021 | $1,251,000 | -65.8% | 105,204 | -53.3% | 0.14% | -55.0% |
| Q3 2021 | $3,655,000 | -53.0% | 225,083 | -39.1% | 0.31% | -41.6% |
| Q2 2021 | $7,779,000 | +11.3% | 369,714 | -17.9% | 0.53% | -1.9% |
| Q1 2021 | $6,989,000 | +232.8% | 450,064 | +350.1% | 0.54% | +188.2% |
| Q4 2020 | $2,100,000 | +48.6% | 100,000 | +42.9% | 0.19% | +33.8% |
| Q3 2020 | $1,413,000 | – | 70,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |